Form 8-K - Current report:
SEC Accession No. 0001104659-24-126533
Filing Date
2024-12-09
Accepted
2024-12-09 08:00:22
Documents
22
Period of Report
2024-12-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2430479d1_8k.htm   iXBRL 8-K 40343
2 EXHIBIT 4.1 tm2430479d1_ex4-1.htm EX-4.1 104789
3 EXHIBIT 4.2 tm2430479d1_ex4-2.htm EX-4.2 96708
4 EXHIBIT 5.1 tm2430479d1_ex5-1.htm EX-5.1 15478
5 EXHIBIT 10.1 tm2430479d1_ex10-1.htm EX-10.1 175190
6 EXHIBIT 99.1 tm2430479d1_ex99-1.htm EX-99.1 11048
10 GRAPHIC tm2430479d1_ex5-1img01.jpg GRAPHIC 12498
11 GRAPHIC tm2430479d1_ex5-1img02.jpg GRAPHIC 1483
12 GRAPHIC tm2430479d1_ex99-1img01.jpg GRAPHIC 7018
13 GRAPHIC tm2430479d1_ex99-1img02.jpg GRAPHIC 2548
  Complete submission text file 0001104659-24-126533.txt   763425

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA eyen-20241205.xsd EX-101.SCH 3015
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20241205_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20241205_pre.xml EX-101.PRE 22359
24 EXTRACTED XBRL INSTANCE DOCUMENT tm2430479d1_8k_htm.xml XML 3666
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 241533885
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)